Estudio diagnóstico de Parkinson

DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging Demonstrates Impact on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome DaTscanTM (ioflupane 123I injection) US FDA-approved in January 2011, is the first FDA-approved radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emissionparkinsonian computed tomography (SPECT) brain imaging to assist in the […]